Epigenetics and ovarian cancer

Cancer Treat Res. 2009:149:131-46. doi: 10.1007/978-0-387-98094-2_6.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Carcinoma / drug therapy
  • Carcinoma / genetics*
  • Cell Transformation, Neoplastic / genetics
  • Combined Modality Therapy
  • DNA Methylation / drug effects
  • DNA, Neoplasm / genetics
  • Epigenesis, Genetic*
  • Female
  • Gene Expression Regulation, Neoplastic / genetics
  • Genes, Tumor Suppressor*
  • Histone Deacetylase Inhibitors / therapeutic use
  • Humans
  • MicroRNAs / genetics
  • Mutation
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / genetics*
  • Therapies, Investigational

Substances

  • Antineoplastic Agents
  • DNA, Neoplasm
  • Histone Deacetylase Inhibitors
  • MicroRNAs